SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
AVANIR Pharmaceuticals Announces FDA Acceptance Of IND For AVP-923 For The Treatment Of Agitation In Patients With Alzheimer's Disease